Network Pharmacology-based Research of Active Components of Albiziae Flos and Mechanisms of Its Antidepressant Effect

Abstract

Albiziae Flos (AF) has been experimentally proven to have an antidepressant effect. However, due to the complexity of botanical ingredients, the exact pharmacological mechanism of action of AF in depression has not been completely deciphered. This study used the network pharmacology method to construct a component-target-pathway network to explore the active components and potential mechanisms of action of AF. The methods included collection and screening of chemical components, prediction of depression-associated targets of the active components, gene enrichment, and network construction and analysis. Quercetin and 4 other active components were found to exert antidepressant effects mainly via monoaminergic neurotransmitters and cAMP signaling and neuroactive ligand-receptor interaction pathways. DRD2, HTR1A, and SLC6A4 were identified as important targets of the studied bioactive components of AF. This network pharmacology analysis provides guidance for further study of the antidepressant mechanism of AF.

Keywords

Albiziae Flos / network pharmacology / antidepressant / active components / signaling pathways

References

[1] HuaH, FengL, ZhangXP, et al.. Anti-angiogenic activity of julibroside J8, a natural product isolated from Albizia julibrissin. Phytomedicine, 2009, 16(8): 703-711

[2] JungYH, HaRR, KwonSH, et al.. Anxiolytic effects of Julibroside C1 isolated from Albizzia julibrissin in mice. Prog Neuro-Psychopharmacol Biol Psychiatry, 2013, 44: 184-192

[3] LiuJ, LvYW, ShiJL, et al.. Anti-Anxiety Effect of (−)-Syringaresnol-4-O-β-d-apiofuranosyl-(1→2)-β-d-glucopyranoside from Albizzia julibrissin Durazz (Leguminosae). Molecules, 2017, 22(8): 1331

[4] YahagiT, DaikonyaA, KitanakaS. Flavonol acylglycosides from flower of Albizia julibrissin and their inhibitory effects on lipid accumulation in 3T3-L1 cells. Chem Pharm Bull, 2012, 60(1): 129-136

[5] KimJH, KimSY, LeeSY, et al.. Antidepressant-like effects of Albizzia julibrissin in mice: involvement of the 5-HT1A receptor system. Pharmacol Biochem Behave, 2007, 87(1): 41-47

[6] LiJ, LiuQT, ChenY, et al.. Involvement of 5-HT1A Receptors in the Anxiolytic-Like Effects of Quercitrin and Evidence of the Involvement of the Monoaminergic System. Evid Based Complement Alternat Med, 2016, 2016: 1-10

[7] XieW, MengX, ZhaiY, et al.. Panax notoginseng saponins: A review of its mechanisms of antidepressant or anxiolytic effects and network analysis on phytochemistry and pharmacology. Molecules, 2018, 23(4): 940

[8] TianS, LiY, WangJ, et al.. ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints. Mol Pharmaceutics, 2011, 8(3): 841-851

[9] LiS, WangN, HongM, et al.. Hepatoprotective effects of a functional formula of three Chinese medicinal herbs: experimental evidence and network pharmacology-based identification of mechanism of action and potential bioactive components. Molecules, 2018, 23(2): 352

[10] RuJ, LiP, WangJ, et al.. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminf, 2014, 6(1): 13

[11] LiuZ, GuoF, WangY, et al.. BATMAN-TCM: a bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine. Sci Rep, 2016, 6: 21146

[12] YuG, WangLG, HanY, et al.. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS: J Integr Biol, 2012, 16(5): 284-287

[13] ShannonP, MarkielA, OzierO, et al.. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 2003, 13(11): 2498-2504

[14] SzklarczykD, MorrisJH, CookH, et al.. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res, 2017, 45(1): 362-368

[15] WuS, YangY, LiuB, et al.. A novel anti-platelet aggregation target of chinensinaphthol methyl ether and neojusticin B obtained from Rostellularia procumbens (L.) Nees. J Enzyme Inhib Med Chem, 2019, 34(1): 999-1009

[16] YoudimKA, QaiserMZ, BegleyDJ, et al.. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radical Biol Med, 2004, 36(5): 592-604

[17] HuebbeP, WagnerAE, Boesch-SaadatmandiC, et al.. Effect of dietary quercetin on brain quercetin levels and the expression of antioxidant and Alzheimer’s disease relevant genes in mice. Pharmacol Res, 2010, 61(3): 242-246

[18] SawmillerD, LiS, ShahaduzzamanM, et al.. Luteolin reduces Alzheimer’s disease pathologies induced by traumatic brain injury. Int J Mol Sci, 2014, 15(1): 895-904

[19] Moradi-AfrapoliF, OufirM, WalterFR, et al.. Validation of UHPLC-MS/MS methods for the determination of kaempferol and its metabolite 4-hydroxyphenyl acetic acid, and application to in vitro blood-brain barrier and intestinal drug permeability studies. J Pharm Biomed Anal, 2016, 128: 264-274

[20] KenjiM, HaruhikoS, HitomiA, et al.. Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator. J Pharmacol Exp Ther, 2014, 350(3): 589-604

[21] RinwaP, KumarA. Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats. Neuroscience, 2013, 255(7): 86-98

[22] MitsueI, KenichiK, MikaY, et al.. Luteolin shows an antidepressant-like effect via suppressing endoplasmic reticulum stress. Biol Pharm Bull, 2011, 34(9): 1481-1486

[23] SuS, HsiehCL, WuSL, et al.. Transcriptomic analysis of EGb 761-regulated neuroactive receptor pathway in vivo. J Ethnopharmacol, 2009, 123(1): 68-73

[24] SuSY, HsiehCL, WuSL, et al.. Transcriptomic analysis of EGb 761-regulated neuroactive receptor pathway in vivo. J Ethnopharmacol, 2009, 123(1): 68-73

[25] HirschfeldR. History and evolution of the monoamine hypothesis of depression. J Clin Psychiat, 2000, 61: 4-6

[26] DunlopBW, NemeroffCB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry, 2007, 64(3): 327-337

[27] KanekoA, ChoS, KiraiK, et al.. Hange-koboku-to, a Kampo medicine, modulates cerebral levels of 5-HT (5-hydroxytryptamine), NA (noradrenaline) and DA (dopamine) in mice. Phytother Res, 2005, 19(6): 491-495

[28] CoppenA. The biochemistry of affective disorders. Br J Psychiatry, 1967, 113(504): 1237-1264

[29] WangH, ZhangY, QiaoM. Mechanisms of extracellular signal-regulated kinase/cAMP response element-binding protein/brain-derived neurotrophic factor signal transduction pathway in depressive disorder. Neural Regener Res, 2013, 8(9): 843-852

[30] YuanP, ZhouR, YunW, et al.. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. J Affective Disord, 2010, 124(1): 164-169

[31] WangJQ, FibuchEE, MaoL. Regulation of mitogen-activated protein kinases by glutamate receptors. J Neurochem, 2007, 100(1): 1-11